RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
207 hedge funds and large institutions have $3.62B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2020 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 74 increasing their positions, 63 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
207
Holders Change
-7
Holders Change %
-3.27%
% of All Funds
4.25%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.18%
New
38
Increased
74
Reduced
63
Closed
43
Calls
$71.1M
Puts
$51.8M
Net Calls
+$19.3M
Net Calls Change
-$52.6M
